Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Aldo Riesgo

Orthopaedic Surgery Miami, FL Medical Doctor

NPI 1639461460 CMS profile 2319308

8940 N Kendall Dr Ste 601E, Miami, FL 33176

Open in the dashboard

General payments

$709,263

732 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Aldo Riesgo of Miami, FL is reported in the CMS Open Payments database as having received $709,263 across 732 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $233,427 162
2024 General $241,340 208
2023 General $160,910 158
2022 General $41,069 61
2021 General $20,606 38
2020 General $5,933 21
2019 General $5,978 84

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Aldo Riesgo
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Aldo Riesgo were reported at $233,427. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Aldo Riesgo Orthopaedic Surgery median Middle half National median
2019 $5,978 $644 $140–$2,844 $163
2020 $5,933 $312 $75–$1,860 $114
2021 $20,606 $520 $117–$2,495 $132
2022 $41,069 $598 $128–$2,731 $149
2023 $160,910 $461 $128–$2,264 $160
2024 $241,340 $497 $134–$2,475 $164
2025 $233,427 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Zimmer Biomet Holdings, Inc. $559,513 508 payments
  2. Stryker Corporation $113,936 181 payments
  3. Sanara MedTech Inc. $34,808 23 payments
  4. DePuy Synthes Sales Inc. $159 2 payments
  5. Biocomposites Inc $145 2 payments
  6. Innovation Technologies Inc $129 1 payment
  7. Ethicon US, LLC $115 1 payment
  8. Onkos Surgical, Inc. $88 1 payment
  9. Globus Medical, Inc. $82 1 payment
  10. Smith+Nephew, Inc. $80 3 payments
  11. Other $208 9 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $307,775 111 payments
  2. Education $304,128 85 payments
  3. Travel and Lodging $44,534 180 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $31,744 6 payments
  5. Food and Beverage $21,083 350 payments
Products named General payments · program years 2019–2025
  1. Arcos $208,814 101 payments
  2. G7 $189,748 81 payments
  3. Persona $165,186 131 payments
  4. Avenir $148,538 62 payments
  5. MAKO $74,406 74 payments
  6. Taperloc $39,088 13 payments
  7. CellerateRx $34,470 22 payments
  8. TRIATHLON $30,535 19 payments
  9. INSIGNIA $23,946 8 payments
  10. RESTORATION $19,274 7 payments
  11. Other $107,127 196 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 10 drugs

Part D claims

260

Median for Orthopedic Surgery: 203

Drug cost

$5,813

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Cefadroxil Generic 11 $1,614
Fluconazole Generic 12 $1,188
Doxycycline Hyclate Generic 21 $847
Diclofenac Sodium Generic 64 $761
Mupirocin Generic 87 $660
Minocycline Hcl Generic 15 $524
Methylprednisolone Generic 12 $96
Gabapentin Generic 13 $74
Amoxicillin Generic 12 $28
Meloxicam Generic 13 $21

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 63 billing codes

Paid by Medicare

$202,567

Medicare's payments for the services billed

Medicare patients

227

Average age 74

Services billed

496

139 women, 88 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Chronic kidney disease 36%
Diabetes 33%
Depression 32%
Ischemic heart disease 31%
Osteoporosis 29%
Atrial fibrillation 23%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

732 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record